| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
Revenues | ||||||
Premiums | ||||||
39,714 | 36,113 | 32,491 | 30,824 | |||
Net investment income | ||||||
1,390 | 1,480 | 1,226 | 1,147 | |||
Total revenues | ||||||
153,566 | 48,650 | 41,806 | 39,838 | |||
Benefits and expenses | ||||||
Pharmacy and other service costs | ||||||
97,668 | 4,793 | 2,456 | 2,468 | |||
Medical costs and other benefit expenses | ||||||
30,819 | 27,528 | 25,263 | 24,341 | |||
Selling, general and administrative expenses | ||||||
14,053 | 11,934 | 10,030 | 9,790 | |||
Amortization of acquired intangible assets | ||||||
2,949 | 235 | 115 | 151 | |||
Total benefits and expenses | ||||||
145,489 | 44,490 | 37,864 | 36,750 | |||
Income from operations | ||||||
8,077 | 4,160 | 3,942 | 3,088 | |||
Interest expense and other | ||||||
-1,682 | -498 | -252 | -278 | |||
Debt extinguishment costs | ||||||
-2 | 0 | -321 | 0 | |||
Net realized investment gains (losses) | ||||||
177 | -81 | 237 | 169 | |||
Income before income taxes | ||||||
6,570 | 3,581 | 3,606 | 2,979 | |||
Total income taxes | ||||||
1,450 | 935 | 1,374 | 1,136 | |||
Net income | ||||||
5,120 | 2,646 | 2,232 | 1,843 | |||
Less: net income attributable to noncontrolling interests | ||||||
16 | 9 | -5 | -24 | |||
Shareholders’ net income | ||||||
5,104 | 2,637 | 2,237 | 1,867 | |||
Shareholders’ net income per share | ||||||
Basic (in dollars per share) | ||||||
13.58 | 10.69 | 8.92 | 7.31 | |||
Diluted (in dollars per share) | ||||||
13.44 | 10.54 | 8.77 | 7.19 | |||
Pharmacy revenues | ||||||
Revenues | ||||||
103,099 | 5,479 | 2,979 | 2,966 | |||
Fees and other revenues | ||||||
Revenues | ||||||
9,363 | 5,578 | 5,110 | 4,901 | |||